Adlai Nortye (ANL) Assets Average (2023 - 2025)
Adlai Nortye's (ANL) quarterly Assets Average came in at $53.2 million in Q4 2025, down 40.5% year-on-year from $89.5 million in Q4 2024, and down 25.7% on a QoQ basis from $71.7 million in Q2 2025.
Adlai Nortye (ANL) Assets Average (2023 - 2025) Analysis & Trends
Adlai Nortye (ANL) has 3 years of Assets Average data on file, last reported at $53.2 million in Q4 2025.
- On a quarterly basis, Assets Average fell 40.5% year-over-year to $53.2 million in Q4 2025; TTM through Dec 2025 was $53.2 million, a 40.5% decrease from a year earlier, with the FY2025 full-year figure at $52.9 million, down 47.53% from the prior year.
- Assets Average for Q4 2025 stood at $53.2 million, down from $71.7 million in the prior quarter.
- Over the last five years, Assets Average for ANL reached as high as $118.9 million in Q2 2024 and fell as low as $53.2 million in Q4 2025.
- Historically, Assets Average has averaged $86.9 million across 3 years, with a median of $89.5 million in 2024.
- Across the five-year window, Assets Average dropped 11.75% in 2024 and sank 40.5% in 2025, its largest moves.
- Year by year, Assets Average stood at $101.4 million in 2023, then retreated by 11.75% to $89.5 million in 2024, then sank by 40.5% to $53.2 million in 2025.
- Per Business Quant data, the three most recent Assets Average figures were $53.2 million in Q4 2025, $71.7 million in Q2 2025, and $89.5 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 65.01 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 40.89 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 8.37 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.30 Bn |
| 10 | Adlai Nortye | 1.16 Bn | 1.15 Bn | - | 53.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 53.24 Mn |
| Jun 30, 2025 | 71.66 Mn |
| Dec 31, 2024 | 89.48 Mn |
| Jun 30, 2024 | 118.94 Mn |
| Dec 31, 2023 | 101.39 Mn |